SG11201504483YA - Compositions comprising vortioxetine and donepezil - Google Patents
Compositions comprising vortioxetine and donepezilInfo
- Publication number
- SG11201504483YA SG11201504483YA SG11201504483YA SG11201504483YA SG11201504483YA SG 11201504483Y A SG11201504483Y A SG 11201504483YA SG 11201504483Y A SG11201504483Y A SG 11201504483YA SG 11201504483Y A SG11201504483Y A SG 11201504483YA SG 11201504483Y A SG11201504483Y A SG 11201504483YA
- Authority
- SG
- Singapore
- Prior art keywords
- vortioxetine
- donepezil
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261736799P | 2012-12-13 | 2012-12-13 | |
| PCT/EP2013/076337 WO2014090929A1 (en) | 2012-12-13 | 2013-12-12 | Compositions comprising vortioxetine and donepezil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504483YA true SG11201504483YA (en) | 2015-07-30 |
Family
ID=49943326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504483YA SG11201504483YA (en) | 2012-12-13 | 2013-12-12 | Compositions comprising vortioxetine and donepezil |
Country Status (44)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105218482B (en) * | 2014-06-24 | 2018-04-06 | 杭州和泽医药科技有限公司 | The preparation method of Vortioxetine hydrobromate beta crystal |
| CN104610195B (en) * | 2015-01-30 | 2017-06-27 | 上虞京新药业有限公司 | The aspartate of Vortioxetine or its hydrate and its production and use |
| CN105315184B (en) * | 2015-06-26 | 2017-03-29 | 上海医药工业研究院 | A kind of fertile Preparation Method And Their Intermediate for Xi Ting |
| CA2992161A1 (en) * | 2015-07-17 | 2017-01-26 | Institut Pasteur | 5-hydroxytryptamine 1b receptor-stimulating agent for use as a promoter of satellite cells self-renewal and/or differentiation |
| CN105534933A (en) * | 2016-01-19 | 2016-05-04 | 美吉斯制药（厦门）有限公司 | Vortioxetine orally disintegrating tablet and preparation method thereof |
| SG11201810644TA (en) | 2016-07-01 | 2018-12-28 | H Lundbeck As | Vortioxetine dosing regimes for fast onset of antidepressant effect |
| US10398691B2 (en) | 2017-03-30 | 2019-09-03 | Rundle Research, LLC | Methods of treating depression |
| ES2890326T3 (en) * | 2017-03-30 | 2022-01-18 | Rundle Res Llc | Vortioxetine and MAO inhibitors to treat depression |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK569087A (en) | 1986-10-31 | 1988-05-01 | Sumitomo Pharma | QUINOLINE DERIVATIVES, THEIR PREPARATION AND USE |
| IT1225462B (en) | 1987-04-03 | 1990-11-14 | Mediolanum Farmaceutici Srl | ORGANIC SALTS OF PHYSOSTIGMIN DERIVATIVES |
| KR100195399B1 (en) | 1987-05-04 | 1999-06-15 | 보니데이비스 | Compounds for the treatment of alzheimer's disease |
| EP0403713A1 (en) | 1989-06-22 | 1990-12-27 | Merrell Dow Pharmaceuticals Inc. | Novel acetylcholinesterase inhibitors |
| US4914102A (en) | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
| TW200462B (en) | 1990-09-27 | 1993-02-21 | Hoechst Roussel Pharma | |
| US5246947A (en) | 1991-09-23 | 1993-09-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1,2-benzisothiazoles and their use for treating depression |
| US5231093A (en) | 1991-10-01 | 1993-07-27 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
| ES2042384B1 (en) | 1991-12-26 | 1994-06-01 | Boehringer Ingelheim Espana | PROCEDURE FOR OBTAINING BIS-PYRIDINE DERIVATIVES. |
| SE9302080D0 (en) | 1993-06-16 | 1993-06-16 | Ab Astra | NEW COMPOUNDS |
| EP0892796B1 (en) | 1996-04-12 | 2001-10-24 | Aventis Pharmaceuticals Inc. | Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| UA81749C2 (en) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Derivated of phenylpiperazine as serotonin reuptake inhibitorS |
| AU2003221117A1 (en) | 2002-03-29 | 2003-10-13 | Eisai Co., Ltd. | (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative |
| DE60324788D1 (en) * | 2002-05-31 | 2009-01-02 | Lundbeck & Co As H | COMBINATION OF AN NMDA ANTAGONIST AND ACETYLCHOLINESTERASE INHIBITORS TO TREAT ALZHEIMER DISEASE |
| NZ541282A (en) * | 2002-12-24 | 2009-02-28 | Bellus Health International Ltd | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| WO2007129427A1 (en) * | 2006-05-08 | 2007-11-15 | Teikoku Seiyaku Co., Ltd. | Tansdermally absorbable preparation comprising anti-dementia agent |
| CA2649576A1 (en) * | 2006-06-09 | 2007-12-21 | Wyeth | Method for enhancing cognitive function |
| CN102617513B (en) | 2006-06-16 | 2015-09-23 | H.隆德贝克有限公司 | As be used for the treatment of cognitive impairment, 1-[2-(2, the 4-dimethylphenylsulfanyl)-phenyl] piperazine of the compound to serotonin reabsorption, 5-HT3 and 5-HT1A activity with combination |
| WO2009005519A1 (en) * | 2007-06-29 | 2009-01-08 | Accera, Inc. | Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism |
| TW200932233A (en) | 2007-11-13 | 2009-08-01 | Lundbeck & Co As H | Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity |
| TW201033181A (en) | 2009-02-17 | 2010-09-16 | Lundbeck & Co As H | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine |
-
2013
- 2013-12-12 RU RU2015122256A patent/RU2635528C2/en active
- 2013-12-12 AR ARP130104651A patent/AR093939A1/en not_active Application Discontinuation
- 2013-12-12 NZ NZ708595A patent/NZ708595A/en unknown
- 2013-12-12 MY MYPI2015001479A patent/MY171802A/en unknown
- 2013-12-12 EP EP13818702.6A patent/EP2931276B1/en active Active
- 2013-12-12 EA EA201590932A patent/EA028300B1/en not_active IP Right Cessation
- 2013-12-12 PE PE2015000879A patent/PE20151026A1/en active IP Right Grant
- 2013-12-12 US US14/649,087 patent/US9211288B2/en active Active
- 2013-12-12 BR BR112015013675-3A patent/BR112015013675B1/en active IP Right Grant
- 2013-12-12 PL PL13818702T patent/PL2931276T3/en unknown
- 2013-12-12 ME MEP-2018-66A patent/ME03029B/en unknown
- 2013-12-12 GE GEAP201313850A patent/GEP201706739B/en unknown
- 2013-12-12 DK DK13818702.6T patent/DK2931276T3/en active
- 2013-12-12 MX MX2015007269A patent/MX362886B/en active IP Right Grant
- 2013-12-12 SI SI201330970T patent/SI2931276T1/en unknown
- 2013-12-12 KR KR1020157015715A patent/KR102171152B1/en active IP Right Grant
- 2013-12-12 MA MA38253A patent/MA38253B1/en unknown
- 2013-12-12 CN CN201380065034.2A patent/CN104853755B/en active Active
- 2013-12-12 LT LTEP13818702.6T patent/LT2931276T/en unknown
- 2013-12-12 AU AU2013357308A patent/AU2013357308B2/en active Active
- 2013-12-12 SG SG11201504483YA patent/SG11201504483YA/en unknown
- 2013-12-12 PT PT138187026T patent/PT2931276T/en unknown
- 2013-12-12 CA CA2893468A patent/CA2893468C/en active Active
- 2013-12-12 ES ES13818702.6T patent/ES2663680T3/en active Active
- 2013-12-12 UA UAA201506381A patent/UA114016C2/en unknown
- 2013-12-12 AP AP2015008498A patent/AP2015008498A0/en unknown
- 2013-12-12 WO PCT/EP2013/076337 patent/WO2014090929A1/en active Application Filing
- 2013-12-12 HU HUE13818702A patent/HUE036280T2/en unknown
- 2013-12-12 RS RS20180285A patent/RS56949B1/en unknown
- 2013-12-12 JP JP2015547020A patent/JP6257641B2/en active Active
-
2014
- 2014-03-05 NO NO14709546A patent/NO2970700T3/no unknown
-
2015
- 2015-05-27 TN TNP2015000235A patent/TN2015000235A1/en unknown
- 2015-06-03 IL IL239192A patent/IL239192B/en active IP Right Grant
- 2015-06-03 DO DO2015000133A patent/DOP2015000133A/en unknown
- 2015-06-08 GT GT201500143A patent/GT201500143A/en unknown
- 2015-06-08 PH PH12015501302A patent/PH12015501302B1/en unknown
- 2015-06-09 CR CR20150303A patent/CR20150303A/en unknown
- 2015-06-09 NI NI201500078A patent/NI201500078A/en unknown
- 2015-06-09 EC ECIEPI201523182A patent/ECSP15023182A/en unknown
- 2015-06-10 CL CL2015001615A patent/CL2015001615A1/en unknown
- 2015-06-12 ZA ZA2015/04274A patent/ZA201504274B/en unknown
-
2016
- 2016-01-18 HK HK16100513.0A patent/HK1212601A1/en unknown
-
2018
- 2018-02-23 HR HRP20180333TT patent/HRP20180333T1/en unknown
- 2018-03-27 CY CY20181100347T patent/CY1120098T1/en unknown
-
2022
- 2022-05-19 AR ARP220101337A patent/AR125920A2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252566B (en) | Pharmaceutical compositions and methods | |
| ZA201408594B (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
| EP2836212A4 (en) | Novel compositions and methods | |
| EP2884984A4 (en) | Therapeutic compositions and methods | |
| HK1207817A1 (en) | Composition comprising herbs | |
| HK1212601A1 (en) | Compositions comprising vortioxetine and donepezil | |
| ZA201501124B (en) | Trans-clomiphene formulations and uses thereof | |
| HK1216250A1 (en) | 8-hydroxy-dihydroergotamine compounds and compositions 8-- | |
| GB201315350D0 (en) | Methods and compositions | |
| GB201315347D0 (en) | Methods and compositions | |
| EP2874641A4 (en) | Glutathione-elevating compositions and uses thereof | |
| EP2879670A4 (en) | Antibacterial compositions and methods | |
| HK1210809A1 (en) | Beta-hexosyl-transferases and uses thereof | |
| EP2852662A4 (en) | Herpesvirus compositions and related methods | |
| HK1231520A1 (en) | Improved matrix stability compositions and methods | |
| EP2834635A4 (en) | Heparin-bulking agent compositions and methods thereof | |
| GB201208315D0 (en) | Pharmaceutical methods and compositions | |
| RS56379B1 (en) | Dermo-protective and dermo-balancing composition |